ConductScience.org, home

Paper36770760

eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design.

Klupt KA and 1 other. Molecules, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design. Papers, record 36770760. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770760

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design.
PubMed
Journal
Molecules
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2023-02-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klupt KAKody A
2Jia ZZongchaohttps://orcid.org/0000-0002-9322-9394

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Signal TransductionMajor topic
NeoplasmsMajor topic
Rats
Animals
Phosphorylation
Protein Processing, Post-Translational
Drug Design
Elongation Factor 2 Kinase

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RGPIN-2018-04427Natural Sciences and Engineering Research Council of CanadaRGPIN201804PubMed

Source NIH RePORTER

Download CSV of grants

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19115238Identification of a protein kinase from Dictyostelium with homology to the novel catalytic domain of myosin heavy chain kinase A.J Biol Chem1997https://conductscience.org/library/papers/9115238PubMed
227818922A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors.Acta Pharm Sin B2016https://conductscience.org/library/papers/27818922PubMed
321624888SwissDock, a protein-small molecule docking web service based on EADock DSS.Nucleic Acids Res2011https://conductscience.org/library/papers/21624888PubMed
433890716Structural dynamics of the complex of calmodulin with a minimal functional construct of eukaryotic elongation factor 2 kinase and the role of Thr348 autophosphorylation.Protein Sci2021https://conductscience.org/library/papers/33890716PubMed
521378847The rise of fragment-based drug discovery.Nat Chem2009https://conductscience.org/library/papers/21378847PubMed
68307162Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine.FEBS Lett1994https://conductscience.org/library/papers/8307162PubMed
734561912Target highlights in CASP14: Analysis of models by structure providers.Proteins2021https://conductscience.org/library/papers/34561912PubMed
821677641NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.Nature2011https://conductscience.org/library/papers/21677641PubMed
930678155Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era.Molecules2019https://conductscience.org/library/papers/30678155PubMed
1025224652Reversible covalent inhibition of eEF-2K by carbonitriles.Chembiochem2014https://conductscience.org/library/papers/25224652PubMed
1114583488Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.Cancer Res2003https://conductscience.org/library/papers/14583488PubMed
1211389851Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity.Mol Cell2001https://conductscience.org/library/papers/11389851PubMed
1326009171Regulation and roles of elongation factor 2 kinase.Biochem Soc Trans2015https://conductscience.org/library/papers/26009171PubMed
1424732796A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity.Mol Cell Biol2014https://conductscience.org/library/papers/24732796PubMed
1522329831Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence.Biochemistry2012https://conductscience.org/library/papers/22329831PubMed
1630268477Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.Lung Cancer2018https://conductscience.org/library/papers/30268477PubMed
1726260792Characterization of the Catalytic and Nucleotide Binding Properties of the α-Kinase Domain of Dictyostelium Myosin-II Heavy Chain Kinase A.J Biol Chem2015https://conductscience.org/library/papers/26260792PubMed
1830187647Homology modeling in drug discovery: Overview, current applications, and future perspectives.Chem Biol Drug Des2019https://conductscience.org/library/papers/30187647PubMed
1934293799Highly accurate protein structure prediction for the human proteome.Nature2021https://conductscience.org/library/papers/34293799PubMed
2018675813The alpha-kinases TRPM6 and TRPM7, but not eEF-2 kinase, phosphorylate the assembly domain of myosin IIA, IIB and IIC.FEBS Lett2008https://conductscience.org/library/papers/18675813PubMed

See all 78 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42351693Synaptic Plasticity-Intrinsic Excitability and Antidepressant Discovery.Biomedicines2026https://conductscience.org/library/papers/42351693PubMed
39180059Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide.Cell Biosci2024https://conductscience.org/library/papers/39180059PubMed
39092736Machine Learning Meets Physics-based Modeling: A Mass-spring System to Predict Protein-ligand Binding Affinity.Curr Med Chem2025https://conductscience.org/library/papers/39092736PubMed
37172726Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.J Biol Chem2023https://conductscience.org/library/papers/37172726PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALPK180216PubTator's text mininghttps://conductscience.org/library/genes/80216NCBI Gene
ALPK357538PubTator's text mininghttps://conductscience.org/library/genes/57538NCBI Gene
EEF21938PubTator's text mininghttps://conductscience.org/library/genes/1938NCBI Gene
EEF2K29904PubTator's text mininghttps://conductscience.org/library/genes/29904NCBI Gene
KIR2DL43805PubTator's text mininghttps://conductscience.org/library/genes/3805NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36770760

GET https://conductscience.org/api/papers/v1/36770760/references?page=2